Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Redistribution of Cell Cycle by Arsenic Trioxide Is Associated With Demethylation and Expression Changes of Cell Cycle Related Genes in Acute Promyelocytic Leukemia Cell Line (Nb4) Publisher Pubmed



Hassani S1, 2 ; Khaleghian A3 ; Ahmadian S4 ; Alizadeh S1 ; Alimoghaddam K5 ; Ghavamzadeh A5 ; Ghaffari SH2, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hematology Department, School of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Biochemistry, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
  4. 4. Institute of Biochemistry and Biophysics, University of Tehran, P.O. Box 13145-1384, Tehran, Iran
  5. 5. Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Annals of Hematology Published:2018


Abstract

PML-RARα perturbs the normal epigenetic setting, which is essential to oncogenic transformation in acute promyelocytic leukemia (APL). Transcription induction and recruitment of DNA methyltransferases (DNMTs) by PML-RARα and subsequent hypermethylation are components of this perturbation. Arsenic trioxide (ATO), an important drug in APL therapy, concurrent with degradation of PML-RARα induces cell cycle change and apoptosis. How ATO causes cell cycle alteration has remained largely unexplained. Here, we investigated DNA methylation patterns of cell cycle regulatory genes promoters, the effects of ATO on the methylated genes and cell cycle distribution in an APL cell line, NB4. Analysis of promoter methylation status of 22 cell cycle related genes in NB4 revealed that CCND1, CCNE1, CCNF, CDKN1A, GADD45α, and RBL1 genes were methylated 60.7, 84.6, 58.6, 8.7, 33.4, and 73.7%, respectively, that after treatment with 2 μM ATO for 48 h, turn into 0.6, 13.8, 0.1, 6.6, 10.7, and 54.5% methylated. ATO significantly reduced the expression of DNMT1, 3A, and 3B. ATO induced the expression of CCND1, CCNE1, and GADD45α genes, suppressed the expression of CCNF and CDKN1A genes, which were consistent with decreased number of cells in G1 and S phases and increased number of cells in G2/M phase. In conclusion, demethylation and alteration in the expression level of the cell cycle related genes may be possible mechanisms in ATO-induced cell cycle arrest in APL cells. It may suggest that ATO by demethylation of CCND1 and CCNE1 and their transcriptional activation accelerates G1 and S transition into the G2/M cell cycle arrest. © 2017, Springer-Verlag GmbH Germany, part of Springer Nature.
Related Docs
View other Related Docs
1. Demethylation and Alterations in the Expression Level of the Cell Cycle–Related Genes As Possible Mechanisms in Arsenic Trioxide–Induced Cell Cycle Arrest in Human Breast Cancer Cells, Tumor Biology (2017)
2. Arsenic Trioxide Induces Cell Cycle Arrest and Alters Dna Methylation Patterns of Cell Cycle Regulatory Genes in Colorectal Cancer Cells, Life Sciences (2016)
3. Comprehensive Mutational Analysis of Primary and Relapse Acute Promyelocytic Leukemia, Leukemia (2016)
4. Reciprocal Interconnection of Mirnome-Epigenome in Cancer Pathogenesis and Its Therapeutic Potential, Epigenetics Territory and Cancer (2015)
5. Epigenetic Mechanisms Underlying the Toxic Effects Associated With Arsenic Exposure and the Development of Diabetes, Food and Chemical Toxicology (2017)
6. Comparison of Induction Therapy in Non-High Risk Acute Promyelocytic Leukemia With Arsenic Trioxide or in Combination With Atra, Leukemia Research (2018)
7. Arsenic Trioxide Alters the Microrna Expression Profile of U87 Glioblastoma, Anti-Cancer Agents in Medicinal Chemistry (2016)
8. Significance of Azd1152 As a Potential Treatment Against Aurora B Overexpression in Acute Promyelocytic Leukemia, Annals of Hematology (2016)
Experts (# of related papers)
View all Related Experts
Seyed Hamidollah Ghaffari (9)
Shirzad Nasiri (2)
Other Related Docs
9. Sirna and Epigenetic Aberrations in Ovarian Cancer, Journal of Cancer Research and Therapeutics (2016)
10. Future Challenges and Prospects for the Epigenetics of Autoimmunity, The Epigenetics of Autoimmunity (2018)
11. Disulfiram/Copper Causes Ros Levels Alteration, Cell Cycle Inhibition, and Apoptosis in Acute Myeloid Leukaemia Cell Lines With Modulation in the Expression of Related Genes, Biomedicine and Pharmacotherapy (2018)
12. Non-Coding Rna-Mediated Epigenetic Alterations in Grave's Ophthalmopathy: A Scoping Systematic Review, Non-coding RNA Research (2023)
13. Circulating Ctdna Methylation Quantification of Two Dna Methyl Transferases in Papillary Thyroid Carcinoma, Journal of Cellular Biochemistry (2019)
14. The Gene Expression Profile and Dna Methylation Pattern of Cdh1 and Dnmt1 Genes in Acute Promyelocytic Leukemia (Apl), Reports of Biochemistry and Molecular Biology (2020)
15. Studying the Potential of Upregulated Ptgs2 and Vegf-C Besides Hyper-Methylation of Ptgs2 Promoter As Biomarkers of Acute Myeloid Leukemia, Molecular Biology Reports (2022)
16. Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma, Iranian Journal of Pathology (2019)
17. Blockade of Jak2/Stat3 Intensifies the Anti-Tumor Activity of Arsenic Trioxide in Acute Myeloid Leukemia Cells: Novel Synergistic Mechanism Via the Mediation of Reactive Oxygen Species, European Journal of Pharmacology (2018)
18. Arsenic Trioxide Induction Autophagy in Human Acute Promyelocytic Leukemia, Koomesh (2018)
19. The Inter-Talk Between Mycobacterium Tuberculosis and the Epigenetic Mechanisms, Epigenomics (2020)
20. Synthesis and Biological Evaluation of 1,3,4-Thiadiazole Linked Phthalimide Derivatives As Anticancer Agents, Letters in Drug Design and Discovery (2017)
21. Epigenetic of Retinoic Acid Receptor ß2 Gene in Breast Cancer, Epigenetics Territory and Cancer (2015)
22. Delivery of Disulfiram Into Breast Cancer Cells Using Folate-Receptor-Targeted Plga-Peg Nanoparticles: In Vitro and in Vivo Investigations, Journal of Nanobiotechnology (2016)
23. Genetic, Hematologic and Psychological Aspects of Leukemia, Cancer Genetics and Psychotherapy (2017)